HighVista Strategies’s Ocular Therapeutix OCUL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.74M	Buy	441,573 +97,506	+28%	+$929K	1.03%	23
2025 Q4	$4.18M	Buy	344,067 +237,456	+223%	+$2.88M	1.08%	30
2025 Q3	$1.25M	Buy	106,611 +17,735	+20%	+$212K	0.31%	105
2025 Q2	$825K	Buy	88,876 +3,635	+4%	+$28.5K	0.3%	114
2025 Q1	$625K	Hold	85,241	–	–	0.24%	120
2024 Q4	$728K	Buy	85,241 +20,214	+31%	+$197K	0.27%	113
2024 Q3	$566K	Buy	65,027 +3,168	+5%	+$26.1K	0.2%	119
2024 Q2	$423K	Buy	+61,859	New	+$382K	0.15%	119
2022 Q1	–	Sell	-58,965	Closed	-$411K	–	93
2021 Q4	$411K	Sell	58,965 -10,097	-15%	-$78.4K	0.33%	67
2021 Q3	$691K	Buy	69,062 +7,423	+12%	+$83.4K	0.46%	62
2021 Q2	$875K	Buy	+61,639	New	+$937K	0.62%	31